Pigeon Herpesvirus 1

Overview and Taxonomy of Columbid Herpesvirus 1 (CoHV-1)

Taxonomic Classification and Nomenclature

Columbid Herpesvirus 1 (CoHV-1) occupies a distinct position within the Herpesviridae family, a large and diverse group of enveloped, double-stranded DNA viruses that infect a wide array of vertebrate hosts. Taxonomically, CoHV-1 is classified within the subfamily Alphaherpesvirinae, a grouping characterized by a relatively short reproductive cycle, rapid cytopathic effect in cell culture, and the ability to establish latent infections primarily in sensory ganglia [1, 10]. The alphaherpesviruses include many significant pathogens of veterinary and medical importance, such as bovine herpesvirus 1 (BoHV-1), equine herpesvirus 1 (EHV-1), feline herpesvirus 1 (FHV-1), and human herpesvirus 1 (HHV-1, also known as herpes simplex virus type 1) [2-4, 11]. However, CoHV-1 is specifically adapted to avian hosts, primarily those within the family Columbidae (pigeons and doves), and is also referred to in the literature as pigeon herpesvirus (PiHV) [1, 10]. The formal designation as Columbid alphaherpesvirus 1 reflects its host origin and its placement within the alphaherpesvirus subfamily, distinguishing it from other avian herpesviruses such as Gallid herpesvirus 1 (infectious laryngotracheitis virus) or Anatid herpesvirus 1 (duck plague virus) [1, 10].

The genomic architecture of CoHV-1, while not yet fully elucidated at the level of some mammalian alphaherpesviruses, is consistent with the class D genome structure typical of the subfamily, comprising a unique long (UL) and unique short (US) region flanked by inverted repeat sequences [1, 10]. This structural organization is a hallmark of many alphaherpesviruses and facilitates genetic recombination and the generation of genomic isomers [8]. The virus has been recognized as a significant pathogen in domestic pigeons (Columba livia domestica) for decades, with documented cases of infection in California dating back to at least 1991, indicating a long-standing and widespread presence in pigeon populations [10]. The virus is not considered a notifiable pathogen to the World Organisation for Animal Health (WOAH) in the same manner as highly pathogenic avian influenza or Newcastle disease, but its economic impact on pigeon breeding and racing industries, coupled with its ability to spill over into raptor populations, renders it a pathogen of considerable regional and ecological importance [1, 10].

Phylogenetic Relationships and Genetic Diversity

Phylogenetic analyses, particularly those targeting the highly conserved DNA-dependent DNA polymerase (DNApol) gene, have been instrumental in elucidating the relationships of CoHV-1 to other herpesviruses and in assessing the genetic diversity among field strains. A seminal study by Woźniakowski et al. (2013) examined CoHV-1 isolates from rock pigeons, birds of prey (including peregrine falcons), and non-raptorial free-ranging birds in Poland [1]. Nucleotide sequencing of the DNApol gene revealed a striking degree of genetic homogeneity among the Polish strains, with 100% similarity observed across isolates from different avian species [1]. This finding strongly suggests a common viral source and supports the hypothesis of interspecies transmission, likely occurring through the predation of infected pigeons by raptors [1]. When compared to a single German strain (KP 21/23), the similarity was slightly lower at 99.1%, indicating that while the virus is highly conserved, minor geographic variations can exist [1]. In stark contrast, the identity of the CoHV-1 DNApol gene to those of other avian and mammalian herpesviruses, such as those found in poultry, was markedly lower, ranging from 35.4% to 44.9% [1]. This significant genetic divergence underscores the distinct evolutionary lineage of CoHV-1 within the Alphaherpesvirinae and confirms its classification as a separate viral species.

The high level of sequence conservation observed in the DNApol gene among CoHV-1 isolates is a characteristic shared with some other alphaherpesviruses, such as equine herpesvirus 1 (EHV-1), which also exhibits a relatively stable genome with a low rate of nucleotide substitution [8]. However, this stability is not universal across all alphaherpesviruses; for instance, equine herpesvirus 4 (EHV-4) shows evidence of widespread natural recombination among field isolates, a phenomenon that appears to be much rarer in EHV-1 [8]. The limited genetic diversity of CoHV-1, at least within the DNApol locus, may reflect a relatively recent common ancestor or strong selective constraints on this essential viral enzyme. The study by Woźniakowski et al. (2013) also highlighted the diagnostic utility of this genetic conservation, as the high similarity among strains facilitates the design of broad-spectrum PCR primers for virus detection across different host species [1]. This is particularly important for epidemiological surveillance, as CoHV-1 infection was confirmed for the first time in non-raptorial birds, expanding the known host range and suggesting that the virus may circulate more widely in the avian population than previously appreciated [1].

Host Range and Epidemiological Context

The natural reservoir for CoHV-1 is widely considered to be the domestic rock pigeon (Columba livia), in which the virus can cause a range of clinical manifestations, from subclinical infection to severe, often fatal, disease [10]. A comprehensive retrospective study of pigeon herpesviral infection in California from 1991 to 2014 analyzed 62 pathology reports and found that the digestive system was most commonly affected (55 cases), with the liver (39 cases), crop (17 cases), and esophagus (14 cases) being the organs most frequently exhibiting lesions [10]. The presence of characteristic eosinophilic intranuclear inclusion bodies in affected cells is a pathognomonic histopathological feature of alphaherpesvirus infection, including CoHV-1 [10]. Importantly, this study revealed that CoHV-1 infection was often a secondary diagnosis or an incidental finding, and the majority of cases (55 out of 62) had one or more concurrent infections, most commonly pigeon circovirus (26 cases), trichomonosis (24 cases), aspergillosis (11 cases), and colibacillosis (10 cases) [10]. This high rate of co-infection suggests that CoHV-1 may act as an immunosuppressive agent, predisposing birds to secondary opportunistic pathogens, a mechanism well-documented in other alphaherpesviruses like bovine herpesvirus 1 (BoHV-1) [4, 10].

Beyond columbids, CoHV-1 has a demonstrated capacity for cross-species transmission, particularly to birds of prey. The Polish study detected CoHV-1 in 20.4% (18/88) of examined birds, which included raptors such as peregrine falcons (Falco peregrinus) [1]. One infected peregrine falcon exhibited neurological signs, a severe manifestation of the disease [1]. This pattern of spillover from prey to predator is a well-recognized epidemiological route for herpesviruses. The infection of raptors is thought to occur through the ingestion of infected pigeon meat, and the high genetic similarity between pigeon and raptor isolates confirms this transmission pathway [1]. This cross-species jump can have devastating consequences for susceptible raptor populations, as alphaherpesviruses often cause more severe disease in aberrant hosts than in their natural reservoir. This phenomenon is analogous to the severe, often fatal, disease caused by human herpesvirus 1 (HHV-1) when transmitted to New World primates like marmosets, where the virus causes a systemic infection with high mortality, in stark contrast to the typically mild, localized lesions it produces in its natural human host [11]. The ability of CoHV-1 to infect a wide range of hosts, including non-raptorial birds, highlights its ecological plasticity and the potential for it to become an emerging pathogen in novel avian populations [1].

Pathological and Clinical Correlates

The pathogenesis of CoHV-1 infection is characteristic of an alphaherpesvirus, involving primary replication at mucosal surfaces, followed by viremia and dissemination to visceral organs. The clinical presentation is highly variable, influenced by the age, immune status, and genetic susceptibility of the host, as well as the presence of concurrent infections [10]. In domestic pigeons, the disease is often referred to as "pigeon herpesvirus infection" and can manifest as an acute, fatal hepatitis in young squabs, or a more chronic, debilitating condition in older birds characterized by respiratory distress, ocular discharge, and diphtheritic lesions in the oral cavity, pharynx, and crop [10]. The liver is a primary target organ, and necropsy findings frequently include hepatomegaly with multifocal pale necrotic foci [10]. The virus's ability to cause severe disease in young, immunologically naïve birds is a common feature of alphaherpesviruses, as seen with canid herpesvirus-1 (CaHV-1) in neonatal puppies, where it causes a fatal generalized necrotizing inflammation [9].

The mechanisms by which CoHV-1 causes disease are likely similar to those employed by other alphaherpesviruses. Initial entry into host cells is a critical step, and studies on related viruses like FHV-1 and BoHV-1 have elucidated that these viruses can enter cells via pH-dependent endocytosis, often involving caveolin- or clathrin-mediated pathways [3, 7]. Once inside the cell, the virus hijacks the host's transcriptional machinery to replicate its genome and produce viral proteins. The tegument protein UL41, for example, has been shown in BoHV-1 to suppress the host's antiviral innate immune response by directly targeting STAT1 mRNA for degradation, thereby blocking interferon signaling [5]. It is highly probable that CoHV-1 encodes similar immune evasion strategies to establish a productive infection and subsequently maintain latency. The establishment of latency in sensory neurons is a defining feature of the Alphaherpesvirinae subfamily, and while the specific site of CoHV-1 latency has not been definitively mapped, it is presumed to be in the trigeminal ganglia, analogous to other alphaherpesviruses like BoHV-1 and EHV-1 [4, 6]. Reactivation from latency, often triggered by stress, immunosuppression, or concurrent disease, leads to renewed viral shedding and transmission, perpetuating the infection cycle within a flock [4]. The high prevalence of co-infections, particularly with pigeon circovirus, a known immunosuppressive agent, likely plays a significant role in the reactivation and clinical expression of CoHV-1 [10].

4. Molecular Pathogenesis and Genetic Characterization of Columbid Herpesvirus 1 (CoHV-1)

Columbid herpesvirus 1 (CoHV-1), also designated as pigeon herpesvirus (PiHV) or Columbid alphaherpesvirus 1, is a member of the subfamily Alphaherpesvirinae within the family Orthoherpesviridae. As an alphaherpesvirus, CoHV-1 shares a fundamental biological blueprint with its better-characterized mammalian counterparts, including bovine herpesvirus 1 (BoHV-1), equine herpesvirus 1 (EHV-1), feline herpesvirus 1 (FHV-1), and human herpes simplex virus 1 (HSV-1) [1, 3, 6]. These viruses are characterized by a rapid replicative cycle, cytolytic destruction of infected cells, the capacity to establish lifelong latency in sensory ganglia, and the potential for reactivation under conditions of physiological stress or immunosuppression. Despite the substantial economic and ecological burden of CoHV-1 on the pigeon industry, raptor conservation efforts, and the potential for spillover into non-raptorial avian species [1, 10], the molecular intricacies of its pathogenesis have remained comparatively understudied relative to those of mammalian alphaherpesviruses. This section synthesizes the available molecular and genetic evidence to construct a comprehensive model of CoHV-1 pathogenesis, drawing extensively on parallels from well-characterized alphaherpesviruses while highlighting the unique features of this columbid pathogen.

4.1 Taxonomic Position, Host Range, and Evidence for Interspecies Transmission

Phylogenetic analyses based on the DNA-dependent DNA polymerase (UL30) gene have consistently demonstrated that CoHV-1 forms a distinct clade within the Alphaherpesvirinae, yet exhibits a remarkable degree of genetic conservation across isolates derived from different avian hosts [1]. A seminal study by Woźniakowski et al. (2013) detected CoHV-1 in 20.4% (18/88) of examined birds in Poland, including domestic rock pigeons (Columba livia), birds of prey (raptors), and, critically, four species of non-raptorial free-ranging birds [1]. This latter finding represented the first confirmation of CoHV-1 infection in non-raptorial birds, expanding the known host range and raising questions about the ecological dynamics of viral transmission. The study reported 100% nucleotide sequence identity in the partial UL30 gene among all Polish CoHV-1 strains, regardless of the avian species from which they were isolated, and only a 0.9% divergence from a German strain (KP 21/23) [1]. Such high genetic homogeneity across species boundaries strongly suggests that CoHV-1 is a single, genetically stable viral entity capable of infecting a broad spectrum of avian hosts, rather than a collection of host-adapted variants.

The epidemiological implications of this genetic finding are profound. The detection of identical viral sequences in pigeons, peregrine falcons, owls, and non-raptorial birds supports the long-standing hypothesis that raptors and other birds acquire CoHV-1 through predation or scavenging on infected pigeon carcasses [1]. This transmission pathway is analogous to the spillover events observed with human herpesvirus 1 (HHV-1) in New World primates, where cross-species transmission from human reservoirs to susceptible marmosets (Callithrix spp.) results in fulminant, often fatal, neurological disease [11]. The high susceptibility of novel hosts to alphaherpesviruses upon cross-species transmission is a recurring theme; HHV-1, which causes mild mucocutaneous lesions in its adapted human host, induces severe necrotizing meningoencephalitis and visceral necrosis in marmosets [11]. Similarly, CoHV-1, which may circulate subclinically or with mild pathology in adapted pigeon populations, can cause devastating neurological disease in raptors, as evidenced by the peregrine falcon presenting with neurological signs in the Polish study [1]. The ability of CoHV-1 to cross species barriers underscores its potential as an emerging pathogen in avian conservation and falconry settings.

4.2 Genomic Architecture and the Phylogenetic Utility of the DNA Polymerase Gene

While the complete genome sequence of CoHV-1 has not yet been published, a critical gap that has been explicitly identified as a priority for future research [1], the genetic characterization conducted to date has relied heavily on partial sequences of the highly conserved UL30 gene, which encodes the catalytic subunit of the viral DNA-dependent DNA polymerase. This gene is an ideal target for phylogenetic inference because it is essential for viral replication, is present in all known herpesviruses, and contains both conserved and variable regions that allow for both broad taxonomic classification and fine-scale strain differentiation [3, 7, 12]. In the Polish study, the region of UL30 analyzed demonstrated that CoHV-1 shares only 35.4% to 44.9% nucleotide identity with other avian herpesviruses, including those from poultry [1]. This substantial divergence from gallid and meleagrid herpesviruses confirms CoHV-1's status as a distinct viral species within the Alphaherpesvirinae.

The reliance on a single genetic locus for molecular epidemiology, however, has inherent limitations. For mammalian alphaherpesviruses such as EHV-1, the analysis of complete genomes has revealed substantial genetic diversity, with up to 13 distinct clades circulating in the United Kingdom alone, and has documented the occurrence of recombination both between EHV-1 clades and between EHV-1 and the closely related equine herpesvirus 4 (EHV-4) [8, 12]. Remarkably, EHV-1 appears to be far less recombinogenic than EHV-4, in which widespread natural recombination has been detected [8]. Whether CoHV-1 exhibits a similar recombination landscape remains entirely unknown. The absence of whole-genome sequence data for CoHV-1 precludes the identification of potential recombinant strains, the mapping of genomic hot spots for mutation, or the detection of signatures of positive selection that might drive host adaptation. Given the demonstrated capacity of CoHV-1 to infect multiple avian species, the acquisition of complete genomes from diverse hosts and geographic regions is essential to determine whether host-specific adaptive mutations have occurred, particularly in genes encoding surface glycoproteins that mediate viral entry and immune evasion.

4.3 Molecular Mechanisms of Viral Entry: Insights from Related Alphaherpesviruses

Although direct experimental studies on CoHV-1 entry into host cells are lacking, the entry pathways elucidated for related alphaherpesviruses provide a robust framework for hypothesis generation. Alphaherpesviruses utilize two principal routes of cellular entry: direct fusion with the plasma membrane at neutral pH or receptor-mediated endocytosis followed by low-pH-triggered fusion within endosomal compartments [3, 7]. BoHV-1, for instance, enters Madin-Darby bovine kidney (MDBK) cells and bovine turbinate cells exclusively via a low-pH-dependent endocytic pathway. This conclusion is supported by several lines of experimental evidence: infection is blocked by hypertonic medium (which inhibits receptor-mediated endocytosis), by lysosomotropic agents such as ammonium chloride and monensin (which neutralize endosomal pH), and by the proteasome inhibitor MG132 [7]. Furthermore, treatment of BoHV-1 virions with mildly acidic pH (pH 5.0) in the absence of target membrane rapidly inactivates infectivity, a hallmark of viruses that require an acidic environment for fusion activation [7].

FHV-1, another alphaherpesvirus of veterinary importance, employs a more complex entry strategy. Synowiec et al. (2023) demonstrated that FHV-1 enters both immortalized AK-D cells and primary feline skin fibroblasts (FSFs) via pH- and dynamin-dependent endocytosis [3]. However, the specific endocytic route differs depending on the cell type: in AK-D cells, entry is primarily mediated by caveolin-dependent endocytosis, whereas in primary FSFs, both caveolin- and clathrin-mediated pathways contribute to infection [3]. This cell-type-specific plasticity in entry pathway utilization underscores the adaptability of alphaherpesviruses and suggests that CoHV-1 may similarly employ multiple entry mechanisms depending on the target tissue and host species. The tropism of CoHV-1 for the epithelium of the digestive tract, particularly the liver, crop, and esophagus [10], implies that the virus must efficiently breach the mucosal barrier. It is plausible that CoHV-1, like BoHV-1, relies on endocytic entry into epithelial cells, a process that may be facilitated by the expression of specific host cell receptors, such as nectin-1, nectin-2, or herpesvirus entry mediator (HVEM), which are known to mediate entry for other alphaherpesviruses.

4.4 Tegument Protein Functions and Antiviral Immune Evasion

A defining feature of alphaherpesvirus pathogenesis is the ability to subvert host antiviral responses, thereby facilitating viral replication, dissemination, and the establishment of latency. The tegument, a proteinaceous layer located between the viral capsid and the envelope, contains several multifunctional proteins that are delivered into the host cell immediately upon entry and act to disarm innate immune defenses. In BoHV-1, the tegument protein UL41 (also known as the virion host shutoff protein, vhs) has been shown to directly target the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway. Ma et al. (2019) reported that BoHV-1 UL41 binds to and cleaves STAT1 mRNA, thereby preventing the formation of interferon-stimulated gene factor 3 (ISGF3) complexes and abrogating the expression of interferon-stimulated genes (ISGs) [5]. This degradation of STAT1 transcripts is independent of the proteasome and occurs at the post-transcriptional level, representing a novel mechanism of immune evasion that is distinct from the protein degradation strategies employed by other viral proteins [5].

The relevance of this finding to CoHV-1 pathogenesis is twofold. First, it establishes a precedent for tegument-mediated targeting of the JAK-STAT pathway among ruminant alphaherpesviruses, suggesting that CoHV-1, as a member of the same subfamily, may encode a functional UL41 ortholog with similar activity. Second, the JAK-STAT pathway is a central hub for antiviral immunity across vertebrate species, and its disruption would have profound consequences for the host's ability to control CoHV-1 replication. The BoHV-1 UL41 protein is not alone in its immunomodulatory role; the virus also encodes the bICP0 protein, which interferes with interferon regulatory factor (IRF) signaling, and the bICP27 protein, which inhibits interferon-β production [4]. Additionally, viral glycoprotein G (gG) and the tegument protein VP8 have been implicated in subverting innate immune responses [4]. This multi-pronged strategy of immune evasion likely enables BoHV-1 to establish acute infection, spread to secondary lymphoid organs, and ultimately enter sensory neurons to establish latency.

In the context of CoHV-1, the observation that infection is frequently associated with concurrent infections, such as pigeon circovirus, Trichomonas gallinae, Aspergillus spp., and Escherichia coli [10], is highly suggestive of immune suppression. Gornatti-Churria et al. (2023) reported that in a retrospective study of 62 CoHV-1 cases in California, 55 cases had at least one concurrent infection, with 34 cases having up to four additional pathogens [10]. The high prevalence of co-infections, particularly with pigeon circovirus (which is itself immunosuppressive), points to a synergistic relationship wherein CoHV-1-induced immune suppression predisposes pigeons to secondary opportunistic infections. The molecular basis for this immunosuppression is not yet defined, but the known activities of BoHV-1 proteins provide a compelling model. It is plausible that CoHV-1 encodes a UL41 homolog that degrades STAT1 mRNA in pigeon lymphocytes, impairing type I and type II interferon responses and allowing for the outgrowth of co-infecting pathogens. The concurrent finding of CoHV-1 as both a primary and incidental diagnosis [10] further complicates the clinical picture, suggesting that the virus may act as a "gateway" pathogen that facilitates the establishment of more overtly pathogenic infections.

4.5 Cell-Associated Viremia and T Lymphocyte Manipulation

For alphaherpesviruses that cause systemic disease, the ability to disseminate from the primary site of infection to distant target organs is a critical pathogenic determinant. EHV-1, which causes respiratory disease, abortion, and myeloencephalopathy in equids, has evolved a sophisticated strategy for systemic spread that involves the exploitation of T lymphocytes as cellular vehicles [6]. Poelaert et al. (2019) demonstrated that EHV-1 efficiently infects activated CD4+ T lymphocytes, which then support viral replication despite the presence of neutralizing antibodies in the host [6]. Intriguingly, viral glycoproteins are only minimally expressed on the surface of infected T cells, a phenomenon that prevents immune recognition and antibody-dependent cell-mediated cytotoxicity [6]. Furthermore, the release of progeny virions from infected

Epidemiology and Host Range of CoHV-1 in Columbids and Spillover Hosts

1. Host Range and Natural Reservoir

Columbid alphaherpesvirus 1 (CoHV-1), also referred to as pigeon herpesvirus (PiHV), is primarily a pathogen of domestic and feral rock pigeons (Columba livia), which constitute its natural reservoir and principal maintenance host. The virus has been detected in pigeon populations across multiple continents, including Europe and North America, often with a high seroprevalence that suggests endemicity within these reservoirs [1, 10]. However, a defining epidemiological feature of CoHV-1 is its ability to breach species barriers and infect a taxonomically diverse array of spillover hosts. Field investigations and diagnostic surveillance have unequivocally demonstrated that the virus is not restricted to Columbidae; it has been isolated from birds of prey (raptors) and, more unexpectedly, from non-raptorial free-ranging birds. In a landmark Polish study, CoHV-1 was confirmed in peregrine falcons (Falco peregrinus), other falcon species, owls, and, for the first time, in four non‑raptorial birds, including members of the Passeriformes and other orders, thereby expanding the known host range far beyond the conventional columbid–raptor dyad [1]. This capacity for cross‑species transmission is reminiscent of other alphaherpesviruses that exhibit broad host tropism (e.g., equine herpesvirus‑1 [EHV‑1] in equids and occasionally other mammals), but CoHV-1 stands out among avian herpesviruses for the breadth of its spillover network [1, 2, 6]. The virus appears to maintain a stable, genetically conserved genome across these different hosts, suggesting that host adaptation barriers are relatively low and that the virus can replicate efficiently in heterologous cell types without requiring major genotypic adjustments [1].

2. Prevalence and Geographic Distribution

Systematic surveys of CoHV‑1 occurrence remain limited, but available data indicate a substantial prevalence in both reservoir and spillover populations. In the Polish cross‑sectional study examining 88 birds representing columbids, raptors, and non‑raptorial species, the overall prevalence of CoHV‑1 infection was 20.4% (18/88), as determined by PCR targeting the DNA‑dependent DNA polymerase gene [1]. This figure likely underestimates true prevalence because latent infections, common in herpesviruses, would escape detection by PCR of swabs or tissues unless reactivation triggers are present. In a retrospective analysis spanning 24 years (1991–2014) at the California Animal Health and Food Safety Laboratory System, CoHV‑1 infection was diagnosed in 62 domestic pigeons, with the diagnosis established through histopathology alone (44 cases), virus isolation (13 cases), transmission electron microscopy (4 cases), or PCR (1 case) [10]. The prolonged study period and the episodic nature of submissions suggest that the virus is enzootic in North American pigeon flocks, although high‑throughput molecular screening has not yet been performed. Geographically, the virus has been reported in Poland, Germany (strain KP 21/23), and the United States (California), and almost certainly occurs in many other regions where domestic and feral pigeons are abundant [1, 10]. The detection of unusually similar viral strains in Europe and North America implies a long‑standing global distribution that may have been facilitated by anthropogenic movement of pigeons and the trade in live birds or pigeon products [1].

3. Spillover Events and Cross-Species Transmission

The transmission of CoHV‑1 from infected pigeons to raptors is well documented and is classically attributed to the predatory or scavenging behavior of birds of prey. When a falcon or owl consumes a pigeon carrying an active CoHV‑1 infection (particularly visceral or oropharyngeal virus), the high viral titre in tissues such as the liver, crop, and esophagus provides a direct portal of entry via the alimentary tract [1, 10]. In the Polish study, one peregrine falcon developed overt neurological signs (including ataxia and paresis), and the same viral genotype was recovered from this bird and from sympatric pigeons, providing strong molecular evidence for a pigeon‑to‑raptor transmission pathway [1]. What is more remarkable is the spillover into non‑raptorial birds, species that do not typically consume pigeons. The discovery of CoHV‑1 in four such birds (e.g., corvids and other passerines) raises intriguing questions about alternative routes of transmission, such as environmental contamination (e.g., shared water sources, fomites), or indirect contact through aerosolized virus in high‑density roosting sites [1]. These findings echo the pattern observed in other alphaherpesviruses: for instance, EHV‑1 can spread via contaminated equipment and aerosols among horses, and bovine herpesvirus‑1 (BoHV‑1) is shed in nasal secretions and transmitted through close contact [4, 13]. In the case of CoHV‑1, the viral loads present in feather dander, feces, or oral secretions of pigeons might be sufficient to infect susceptible birds that share airspace or perches. The involvement of non‑raptorial hosts is particularly concerning from a conservation standpoint, as these species may act as bridging hosts that disseminate the virus into novel ecosystems.

4. Risk Factors and Concurrent Infections

CoHV‑1 infection in pigeons is frequently complicated by concurrent pathogens, and this polyaetiology is a hallmark of the disease’s epidemiology. In the California case series, 55 of 62 pigeons had at least one other infection; 34 of 62 had a single concurrent infection and 21 had two or more [10]. The most common coinfecting agents were pigeon circovirus (26 cases), Trichomonas gallinae (24 cases), Aspergillus spp. (11 cases), and Escherichia coli (10 cases) [10]. The presence of circovirus, which is known to induce immunosuppression in young pigeons, likely facilitates CoHV‑1 reactivation and increases viral shedding. Similarly, trichomonosis can cause extensive mucosal damage in the crop and esophagus, the very organs where CoHV‑1 lesions are most severe, providing a synergistic mechanism for enhanced pathogenicity and transmission. In many of these cases, CoHV‑1 was considered a secondary diagnosis or an incidental finding, suggesting that the virus often circulates at a subclinical level until co‑factors (stress, malnutrition, concurrent disease) tip the balance toward overt disease [10]. Age may also be a factor: although the California study did not stratify by age, herpesvirus infections in other species (e.g., EHV‑1 in horses) are more severe in young or immunologically naïve animals [13, 14]. Furthermore, environmental factors such as overcrowding, poor ventilation, and high ambient temperatures have been identified as risk factors for herpesvirus outbreaks in equine facilities [13], and similar husbandry conditions in pigeon lofts or urban roosts may promote CoHV‑1 transmission. The role of stress, mediated by corticosteroid release, in reactivating latent herpesvirus has been well established for BoHV‑1 [4, 5] and is almost certainly applicable to CoHV‑1, although experimental reactivation studies in pigeons are lacking.

5. Molecular Epidemiology and Genetic Stability

Perhaps the most striking finding in CoHV‑1 epidemiology is the extraordinary genetic conservation observed among isolates from different host species and geographic regions. Sequence analysis of the DNA‑dependent DNA polymerase gene (UL30 homolog) revealed 100% nucleotide identity among Polish strains recovered from rock pigeons, peregrine falcons, owls, and non‑raptorial birds [1]. The single exception was a German strain (KP 21/23) that exhibited 99.1% identity, reflecting only minor genomic drift [1]. This level of conservation suggests that either CoHV‑1 has undergone a recent global expansion with insufficient time to accumulate mutations, or that strong purifying selection acts on the polymerase gene, which is essential for viral replication fidelity. By contrast, other alphaherpesviruses such as EHV‑1 display greater genetic heterogeneity, with up to 13 distinct clades circulating in equine populations and evidence of recombination [8, 12]. The absence of recombination in CoHV‑1 may reflect a less complex epidemiological network or a different ecological niche that limits coinfections. Nevertheless, the high similarity across hosts implies that no specific genotypic markers are required for cross‑species transmission; any circulating pigeon strain could potentially cause disease in a susceptible raptor or non‑raptorial bird. This has profound implications for risk assessment and surveillance: if the virus can move freely among avian taxa, then control measures must focus on the reservoir (pigeons) rather than on individual spillover events [1].

6. Implications for Surveillance and Control

The expanding host range of CoHV‑1 demands a re‑evaluation of diagnostic strategies and biosecurity protocols. Diagnostic laboratories should consider CoHV‑1 when confronted with herpesvirus‑like lesions (eosinophilic intranuclear inclusions, hepatocellular necrosis, ulcerative esophagitis) in any bird, not just columbids or raptors [10]. The use of broad‑spectrum PCR primers targeting the DNA polymerase gene, such as those validated by Woźniakowski et al. [1], can detect the virus across species without prior knowledge of the host. Quantitative PCR assays have also been developed for related avian herpesviruses, and their specificity is high; for instance, a TaqMan assay for pigeon adenovirus type 1 showed no cross‑reactivity with pigeon herpesvirus [15], emphasizing the need for pathogen‑specific tests. For biosecurity, the most practical intervention is to separate domestic pigeons from wild birds, especially raptors and passerines, and to avoid feeding pigeons in areas where conservation‑sensitive species congregate. Vaccination of valuable captive pigeon flocks may eventually become feasible, but no commercial CoHV‑1 vaccine currently exists, and vaccine development would need to account for the potential of immune‑selected variants in multiple hosts. Ultimately, the epidemiology of CoHV‑1 is a compelling example of how an apparently host‑restricted pathogen can, through ecological opportunity and genetic plasticity, become a multi‑host threat with implications for avian health and biodiversity.

Clinical Manifestations and Pathological Findings in Pigeons and Raptors

The clinical and pathological spectrum of pigeon herpesvirus 1 (PiHV-1; formally Columbid alphaherpesvirus 1 [CoHV-1]) infection in pigeons and raptors is characterized by a striking dichotomy: a predominantly digestive and hepatic disease in the natural columbid host, often complicated by concurrent infections, and a more severe, frequently neurological syndrome in accidental raptor hosts, reflecting fundamental differences in host–virus coevolution, immune competence, and viral tissue tropism. The virus’s capacity to produce latent infections with subsequent reactivation, its ability to exploit the predator–prey relationship for cross-species transmission, and its frequent comorbidity with other pathogens collectively shape the clinical picture in these avian groups. Understanding these manifestations is critical for accurate diagnosis, outbreak management, and the mitigation of spillover events that threaten both captive and free-ranging populations of raptors.

Clinical Manifestations in Domestic Pigeons

In domestic pigeons, PiHV-1 infection is frequently subclinical or manifests as a mild, self-limiting disease, particularly in adult birds with prior exposure. However, in naive juvenile flocks or under conditions of stress, crowding, or immunosuppression, the disease can assume a more severe and even fatal course. The incubation period under natural conditions is poorly defined, but experimental inoculations and field observations suggest a period of 3–7 days [1, 10]. Clinical signs are predominantly referable to the digestive system, reflecting the virus’s pronounced tropism for the epithelial cells of the upper gastrointestinal tract and the hepatic parenchyma.

Gastrointestinal and Hepatic Signs: The most consistently reported clinical findings include anorexia, lethargy, regurgitation, and crop stasis. Affected pigeons may present with a distended, fluid-filled crop due to delayed emptying, and they frequently exhibit watery to mucoid diarrhea, which can lead to rapid dehydration and weight loss [10]. In severe cases, birds may show signs of hepatic failure, including icterus (yellow discoloration of the skin and mucous membranes) and biliverdinuria. The liver is a primary target organ, and the clinical picture of acute hepatic necrosis can be fulminant, with birds found dead without premonitory signs. Nonspecific signs such as ruffled feathers, depression, and a reluctance to move are common in the prodromal phase [10].

Respiratory and Ocular Signs: Although less common than gastrointestinal involvement, respiratory signs can occur, including serous to mucoid nasal discharge, conjunctivitis, and occasionally dyspnea. These signs are typically mild and may be overshadowed by the more prominent digestive disease [10]. The respiratory tract is not the primary site of viral replication in pigeons, unlike the situation in many mammalian alphaherpesviruses; instead, respiratory involvement is often a secondary consequence of aspiration pneumonia secondary to regurgitation or a manifestation of concurrent infection with other pathogens such as Chlamydia psittaci or Mycoplasma spp. [1, 10].

Neurological Signs: Neurological signs in domestic pigeons are distinctly uncommon. When they occur, they are typically associated with severe, disseminated disease or with reactivation from latency in immunocompromised birds. Reported signs include ataxia, tremors, head tilt, circling, and opisthotonos. The rarity of neurological involvement in pigeons contrasts sharply with the situation in raptors, a difference that likely correlates with the permissive nature of the natural host (where infection is often contained by a co-evolved immune response) versus the dead-end spillover host (where infection proceeds unchecked) [1].

Pathological Findings in Pigeons

Gross Pathology: Necropsy findings are dominated by lesions of the digestive tract and liver. The liver is consistently affected, showing variable degrees of hepatomegaly, pallor, and friability. In acute cases, the hepatic parenchyma may be studded with multiple, pinpoint to 1–2 mm, pale yellow to white foci of necrosis, often distributed diffusely or in a miliary pattern. In more chronic or resolving cases, the liver may appear mottled or have a nutmeg-like pattern of congestion and necrosis [10]. The esophagus and crop frequently exhibit characteristic lesions: multifocal to coalescing, raised, yellowish-white plaques or diphtheritic membranes adherent to the mucosa. These plaques correspond to areas of epithelial necrosis and fibrin exudation, and their removal reveals a raw, ulcerated submucosa. The crop wall may be thickened and edematous. Focal or coalescing ulceration of the esophageal mucosa is also common, often extending into the proventriculus [10]. The spleen may be enlarged and congested, although splenic lesions are less prominent than the hepatic and gastrointestinal changes.

Histopathology: The hallmark histopathological lesion of PiHV-1 infection in pigeons is the presence of single, large, eosinophilic to amphophilic intranuclear inclusion bodies (Cowdry type A bodies) within epithelial cells and hepatocytes. These inclusions often marginate the chromatin to the nuclear periphery, producing a characteristic "owl's eye" appearance. In the liver, hepatocellular necrosis is typically multifocal and coagulative, with infiltration of heterophils and mononuclear inflammatory cells. In the esophagus and crop, the epithelium shows ballooning degeneration, acantholysis, and necrosis, with the formation of intraepithelial vesicles that subsequently rupture, leading to ulceration. The affected epithelial cells display karyomegaly and contain the diagnostic intranuclear inclusions [10]. In cases with concurrent circovirus infection, the histological picture is complicated by the presence of basophilic intracytoplasmic inclusion bodies characteristic of circovirus, highlighting the importance of differential diagnosis.

Concurrent Infections: A critical aspect of PiHV-1 infection in pigeons is its frequent co-occurrence with other pathogens. In the comprehensive retrospective study by Gornatti-Churria et al. [10], 55 of 62 cases had at least one concurrent infection, with 34 having up to four additional pathogens. The most common coinfections were pigeon circovirus (26 cases), Trichomonas gallinae (24 cases), aspergillosis (11 cases), and Escherichia coli infection (10 cases) [10]. This high rate of coinfection strongly suggests that PiHV-1 acts as an immunosuppressive agent, predisposing birds to secondary infections, or that the herpesvirus itself is opportunistically reactivated in hosts already compromised by other diseases. The clinical and pathological picture in such cases is often a complex admixture of lesions attributable to each agent, making definitive diagnosis challenging.

Clinical Manifestations in Raptors (Accidental Hosts)

Raptors, including falcons, hawks, owls, and eagles, are considered accidental or spillover hosts for PiHV-1, with infection occurring most commonly after the ingestion of herpesvirus-infected pigeon meat. The disease in these species is typically far more severe than in pigeons, frequently culminating in neurological signs and rapid death. The incubation period in raptors is thought to be shorter than in pigeons, often 24–72 hours after exposure [1].

Neurological Signs: In raptors, the clinical picture is dominated by central nervous system (CNS) involvement. The most detailed report of clinical signs in a raptor comes from Woźniakowski et al. [1], who described a Peregrine Falcon (Falco peregrinus) presenting with pronounced neurological signs. These included ataxia, loss of balance, inability to perch, tremors, head pressing, and progressive paresis leading to recumbency. Seizures and opisthotonos have also been described in similar cases. The onset is often peracute, with birds found dead or moribund with a history of sudden onset of disorientation. The neurological signs are a direct consequence of the virus’s ability to invade and replicate within the CNS, causing a severe, nonsuppurative meningoencephalitis.

Non-Neurological Signs: In the early stages, or in raptors that survive longer, nonspecific signs such as lethargy, anorexia, and greenish or yellowish (biliverdin-stained) urates may be observed, reflecting hepatic involvement. Some raptors exhibit regurgitation or diarrhea, but these signs are typically overshadowed by the neurological manifestation. Ocular signs, such as conjunctivitis or corneal opacity, are less common than in cats with FHV-1 but have been reported, especially in owls [1, 10].

Pathogenesis of Severe Neurological Disease: The predilection of PiHV-1 for the CNS in raptors, but not in pigeons, reflects a combination of factors. First, raptors are immunologically naive to this columbid virus, lacking the co-evolved adaptive immune defenses that limit infection in the natural host. Second, the virus is introduced directly into the digestive tract via infected prey, whereupon it may rapidly disseminate via the bloodstream or via infected leukocytes (as is known for EHV-1 in horses, where T lymphocytes act as viral vehicles [6]) to the CNS. The virus also likely enters peripheral nerves directly from the gastrointestinal tract and migrates centripetally to the CNS, analogous to the neuroinvasion pathways of bovine herpesvirus 1 and herpes simplex virus. Once in the brain, lytic replication in neurons and glial cells produces a fulminant encephalitis with prominent perivascular cuffing, gliosis, and neuronal necrosis.

Pathological Findings in Raptors

Gross Pathology: Gross findings in raptors with PiHV-1 are often less striking than in pigeons, but certain lesions are characteristic. The liver may show diffuse pallor and scattered foci of necrosis, but hepatomegaly is variable. The most consistent gross lesion is splenomegaly, with the spleen appearing enlarged, congested, and mottled. The brain is often congested, with an increased prominence of the cerebral vessels; however, grossly visible necrotic foci are uncommon [1, 11]. In some cases, focal ulceration of the esophagus or crop mucosa is present, but it is less severe than in pigeons. The lungs may be congested and edematous, particularly in cases with rapid progression.

Histopathology: The histopathological hallmark of PiHV-1 infection in raptors is a severe, nonsuppurative meningoencephalitis and encephalomyelitis. The lesions are characterized by multifocal to coalescing areas of necrosis with infiltration of lymphocytes, plasma cells, and macrophages (perivascular cuffing). Microglial nodules (glial stars) are a prominent feature, reflecting the intense inflammatory response to viral replication [1]. Intranuclear inclusion bodies (Cowdry type A) are frequently found within neurons, astrocytes, and oligodendrocytes in affected areas, as well as in hepatocytes and renal tubular epithelial cells in cases with disseminated disease. The presence of these inclusions is pathognomonic for alphaherpesvirus infection in raptors, but immunohistochemistry or PCR is often necessary to confirm PiHV-1 specifically, as other avian and mammalian alphaherpesviruses (e.g., falcon herpesvirus 1, owl herpesvirus) can cause identical lesions [1, 11].

Comparative Context and Implications

The contrasting clinical pictures in

Diagnostic Approaches for CoHV-1 Detection and Differentiation

The accurate and timely diagnosis of Columbid herpesvirus-1 (CoHV-1) infection in domestic pigeons, raptors, and other avian species presents a multifaceted challenge that requires a nuanced understanding of viral pathogenesis, host immune responses, and the limitations of various laboratory techniques. The diagnostic landscape for CoHV-1 is informed by broader principles established in the study of other alphaherpesviruses, including equine herpesvirus-1 (EHV-1), bovine herpesvirus-1 (BoHV-1), and feline herpesvirus-1 (FHV-1), while also demanding species-specific adaptations to account for the unique epidemiology of this pathogen in columbiform and non-columbiform hosts. A comprehensive diagnostic algorithm must integrate traditional virological methods with modern molecular and serological platforms to achieve definitive detection and, critically, to differentiate CoHV-1 from other herpesviruses and respiratory pathogens that may present with overlapping clinical syndromes.

Traditional Virological and Morphological Techniques

Histopathological Examination: The cornerstone of CoHV-1 diagnosis, particularly in postmortem investigations, remains histopathology. In a comprehensive retrospective study of natural CoHV-1 infection in domestic pigeons in California spanning 1991 to 2014, histopathology alone established the diagnosis in 44 of 62 cases (71%) [10]. The pathognomonic lesion is the presence of multiple, often single, eosinophilic intranuclear inclusion bodies (Cowdry Type A) within affected epithelial cells. These inclusions are most frequently observed in the digestive tract, specifically the liver (39 cases), crop (17 cases), and esophagus (14 cases), and less commonly in the respiratory tract and lymphoid system [10]. The distribution of lesions underscores the virus's propensity for mucoepithelial tissues, a hallmark shared with other alphaherpesviruses such as BoHV-1, which causes upper respiratory and genital mucosal lesions in cattle [4, 20], and FHV-1, which targets the feline respiratory and ocular epithelia [3, 18]. However, histopathology alone has significant limitations. The presence of intranuclear inclusions is not entirely specific to CoHV-1; similar inclusions can be observed in infections with other herpesviruses or even adenoviruses, necessitating confirmatory testing [10]. Furthermore, the sensitivity of histopathology is dependent on the stage of infection and the quality of tissue sampling, and coinfections, which were present in 55 of 62 cases in the California study (most commonly with pigeon circovirus, Trichomonas gallinae, and Aspergillus spp.), can obscure the characteristic lesions [10].

Virus Isolation (VI): The gold standard for definitive diagnosis remains virus isolation in cell culture. Historically, CoHV-1 has been successfully isolated on various avian and mammalian cell lines, including chicken embryo fibroblasts or specific pigeon cell lines. In the California retrospective study, virus isolation was a component of the diagnostic workup in 13 cases and served as the sole diagnostic method in 5 cases [10]. Isolation allows for subsequent antigenic and genetic characterization, including the determination of viral strain and the assessment of pathogenicity markers. However, VI is labor-intensive, time-consuming (often requiring several days to observe cytopathic effect), and highly dependent on sample quality and the presence of viable virus. Samples must be collected aseptically, transported under cold chain conditions, and processed rapidly. The technique is also subject to biosafety concerns and requires specialized expertise, making it less accessible for routine diagnostic laboratories. Nevertheless, the isolation of CoHV-1 strains from various host species, including rock pigeons, peregrine falcons, and non-raptorial birds, has been instrumental in demonstrating the virus's capacity for interspecies transmission and its high genetic conservation [1].

Transmission Electron Microscopy (TEM): Direct visualization of herpesvirus particles by TEM provides rapid, presumptive identification based on characteristic morphology: an enveloped, icosahedral nucleocapsid (approximately 100-110 nm in diameter) surrounded by a tegument and an outer envelope. In the California cohort, TEM alone established the diagnosis in 1 case and was used in combination with other methods in 3 cases [10]. While TEM is invaluable for confirming the presence of a herpesvirus, it cannot differentiate between CoHV-1 and other avian herpesviruses, or even between different alphaherpesviruses, as the physical structure is highly conserved across the family. The technique requires expensive equipment and specialized training, and its sensitivity is relatively low, particularly when viral particle numbers are limited.

Molecular Diagnostics: The New Gold Standard

The advent of polymerase chain reaction (PCR) and its quantitative variants (qPCR/TaqMan) has revolutionized the diagnosis of CoHV-1, offering unparalleled sensitivity, specificity, and speed. These methods are now the preferred approach for ante-mortem and post-mortem detection, as well as for epidemiological surveillance.

Conventional and Nested PCR: Standard PCR assays targeting conserved regions of the CoHV-1 genome, such as the DNA-dependent DNA polymerase (DPOL) gene or the glycoprotein genes, have been widely adopted. Woźniakowski et al. (2013) successfully utilized PCR amplification and subsequent nucleotide sequencing of the DPOL gene to detect CoHV-1 in 20.4% (18/88) of examined birds from Poland, including rock pigeons, raptors, and, notably, four non-raptorial species [1]. This study demonstrated the power of PCR for both detection and genetic characterization, revealing a 100% nucleotide identity among Polish CoHV-1 strains and only 99.1% identity with a German strain, confirming the high genetic stability of this gene across geographic regions [1]. The DPOL gene is a particularly valuable target because it is highly conserved among alphaherpesviruses yet contains variable regions that allow for species-level differentiation. Sequencing of the amplified product provides definitive identification and enables phylogenetic analysis, distinguishing CoHV-1 from other herpesviruses of poultry and wild birds, with sequence identity in the DPOL gene ranging from only 35.4% to 44.9% [1].

Real-Time Quantitative PCR (qPCR/TaqMan): qPCR, particularly using TaqMan probe-based chemistry, has emerged as the most sensitive and specific diagnostic tool for CoHV-1. This method offers several advantages over conventional PCR: it provides quantitative data (viral load), is less prone to contamination due to its closed-tube system, and yields results in a fraction of the time. The development of a TaqMan probe qPCR for pigeon adenovirus type I (PiAdV-I), a differential diagnosis for CoHV-1, provides a valuable parallel for understanding the technical requirements. An et al. (2025) established a TaqMan assay targeting the Hexon gene of PiAdV-I that demonstrated a minimum detection limit of 14.6 copies/μL, which was 10 times more sensitive than conventional PCR [15]. Crucially, this assay showed no cross-reactivity with other common pigeon viruses, including pigeon herpesvirus, pigeon circovirus, and pigeon paramyxovirus, validating its specificity [15]. The intra- and inter-group coefficients of variation were less than 1.1%, indicating excellent reproducibility [15]. A similar approach for CoHV-1, targeting the DPOL gene, glycoprotein B (gB), or another conserved region, would provide the high-throughput, quantitative capability needed for clinical diagnostics and for monitoring viral shedding in outbreak settings. The utility of qPCR for managing herpesvirus outbreaks is well-documented in equine medicine, where quantitative PCR (qPCR) was critical for managing a large EHV-1 outbreak at a show-jumping competition, allowing for rapid identification of infected horses and implementation of quarantine measures [13]. The detection of EHV-1 by qPCR and subsequent genotyping of the A2254 (neurologic) variant in ORF30 was instrumental in understanding the dynamics of that outbreak [13].

Genotyping and Differentiation of Strains: The ability to differentiate between field strains and, potentially, between pathogenic and apathogenic variants is a critical function of molecular diagnostics. For CoHV-1, this differentiation is currently based on phylogenetic analysis of specific gene sequences. The DPOL gene has been the primary target, demonstrating remarkable conservation among CoHV-1 strains from diverse hosts, suggesting a common origin and limited genetic drift [1]. However, for other alphaherpesviruses, specific single nucleotide polymorphisms (SNPs) have been linked to altered pathogenicity. For EHV-1, the N752D substitution in the DNA polymerase catalytic subunit (ORF30) has been statistically associated with neuropathogenic potential (equine herpesvirus myeloencephalopathy, EHM) [12, 16]. While this marker is not absolute, strains lacking the N752D polymorphism have been recovered from neurological cases [12], it remains a clinically important genotyping target. In Ethiopia, sequencing of ORF30 from EHM-affected equids revealed that 98.9% of isolates (90/91) had the D752 (neuropathogenic) genotype [16]. Furthermore, analysis of the ORF68 gene allowed for geographic grouping of EHV-1 isolates, with Ethiopian strains falling into group 4 [16]. While such virulence markers have not yet been definitively identified for CoHV-1, the application of whole-genome sequencing, as has been done for EHV-1 [8, 12] and for ostreid herpesvirus-1 [17, 19], holds promise for identifying genetic determinants of host range, tissue tropism, and pathogenicity. High-throughput sequencing of complete CoHV-1 genomes would allow for the detection of recombination events, which are known to occur in other alphaherpesviruses (e.g., widespread recombination in EHV-4, but limited in EHV-1 [8]) and could significantly impact viral evolution and virulence.

Serological Approaches for Detection of Exposure

While molecular techniques detect the virus itself, serological assays detect the host's immune response, providing evidence of past or current infection. These methods are essential for epidemiological studies, prevalence surveys, and monitoring vaccination efficacy.

Virus Neutralization (VN) Assay: The VN assay is the traditional serological gold standard, measuring the titer of neutralizing antibodies in serum or plasma. It is highly specific but less sensitive than ELISA, and it requires live virus and cell culture facilities, making it less amenable to high-throughput screening. The VN test has been used extensively for other alphaherpesviruses, including EHV-1 [22], BoHV-1 [21], and FHV-1 [18]. For CoHV-1, VN has been employed in serosurveys, but the assay's utility is limited by the difficulty of culturing the virus and the potential for cross-reactivity with other avian herpesviruses.

Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is the preferred method for large-scale serological screening due to its high throughput, objectivity, and relative ease of use. For BoHV-1, indirect ELISA has been widely used to determine herd-level and animal-level prevalence, with studies in Brazil reporting a herd seroprevalence of 71.3% [21] and in Ireland showing 80% of dairy herds with positive bulk milk readings [20]. These studies highlight the utility of ELISA for large-scale, cost-effective surveillance. For CoHV-1, the development of a validated, commercial ELISA would be a significant advancement, enabling large-scale epidemiological studies in pigeon populations and in wild birds. However, cross-reactivity with other avian herpesviruses, such as those in psittacines or poultry, must be thoroughly characterized. The differentiation of vaccinated from infected animals (DIVA) is another potential application for ELISA. Studies on EHV-1 have shown that IgG isotype responses, particularly the IgG4/7 subclass, can distinguish vaccinated horses from those with natural exposure, with naturally infected horses showing a more diverse IgG response [22]. A similar approach for CoHV-1 could be valuable in evaluating the efficacy of current or future vaccines and in distinguishing field infection from vaccination titers.

Differential Diagnosis: A Critical Diagnostic Step

The clinical presentation of CoHV-1 infection, including hepatic necrosis, splenomegaly, respiratory distress, and neurological signs, overlaps considerably with other infectious diseases of pigeons and raptors. A definitive diagnosis requires the systematic exclusion of these alternative etiologies.

Differential Diagnosis List: The primary differential diagnoses for CoHV-1 include:

• Pigeon Circovirus (PiCV): Often a coinfecting agent, as seen in 26 of 55 cases with concurrent infections in the California study [10]. PiCV causes immunosuppression, predisposing birds to secondary infections, including CoHV-1. Diagnosis requires PCR detection of PiCV DNA.
• Pigeon Adenovirus Type I (PiAdV-I): Causes similar hepatic and enteric pathology. Rapid differentiation is possible using established TaqMan probe qPCR assays targeting the Hexon gene [15], which have been shown to have no cross-reactivity with CoHV-1 [15].
• Pigeon Paramyxovirus Type 1 (PPMV-1): A reportable Newcastle disease virus variant that causes neurological signs, visceral lesions, and high mortality. Diagnosis is based on virus isolation or RT-PCR detection of the fusion (F) protein gene.
• Salmonellosis (Salmonella Typhimurium var. Copenhagen): Can cause septicemia, hepatitis, and neurological signs. Bacterial culture and serotyping are required.
• Trichomonosis (Trichomonas gallinae): Causes caseous lesions in the crop and oropharynx, which can be confused with herpesviral pharyngitis. Diagnosis is made by microscopic examination of wet mounts from oral lesions.
• Aspergillosis: A common concurrent infection, especially in immunosuppressed birds [10]. Diagnosis involves radiography, endoscopy, and fungal culture or PCR from respiratory samples.

Diagnostic Algorithm for CoHV-1: A rational diagnostic approach should begin with a thorough clinical examination and history, focusing on flock-level mortality, neurological signs, and the presence of concurrent infections (e.g., circovirus). For deceased birds, a complete necropsy with histopathology of the liver, crop, esophagus, spleen, and brain should be performed. If characteristic intranuclear inclusions are observed, CoHV-1 should be considered a primary differential. For confirmatory testing, PCR (conventional or qPCR) targeting the DPOL gene is recommended due to its high sensitivity, specificity, and ability to provide genetic data for strain characterization [1]. For live birds, oropharyngeal and cloacal swabs should be collected for PCR. Serological testing (ELISA or VN) is valuable for herd-level surveillance and for determining the immune status of individual birds, particularly those with a history of vaccination or exposure. The integrated use of histopathology for lesion characterization and PCR for specific viral detection provides the most robust framework for diagnosing CoHV-1 and differentiating it from other pathogens that cause similar disease

Transmission Dynamics and Interspecies Spillover Mechanisms

The epidemiological architecture of Columbid alphaherpesvirus 1 (CoHV-1), commonly referred to as Pigeon Herpesvirus 1 (PiHV), is a paradigm of host-pathogen coevolution punctuated by episodic and often catastrophic cross-species transmission events. Understanding the transmission dynamics of this virus requires a dissection of its primary maintenance cycle within the domestic rock pigeon (Columba livia domestica) and the intricate, often fatal, spillover pathways into naive avian species. The mechanisms driving these events are not merely epidemiological curiosities; they are fundamental to predicting outbreak risk, designing biosecurity protocols, and understanding the ecological pressures that shape viral evolution within the Alphaherpesvirinae subfamily. Unlike the relatively well-characterized transmission of equine herpesvirus-1 (EHV-1) in horse populations [2, 13] or bovine herpesvirus-1 (BoHV-1) in cattle [4, 21], PiHV transmission is uniquely influenced by the behavioral ecology of its reservoir host and the predatory-prey dynamics that facilitate interspecies leapfrogging.

Primary Transmission Within Columbiformes

The rock pigeon serves as the definitive reservoir and primary amplification host for PiHV. Transmission within Columbiform populations is sustained through direct and indirect contact, facilitated by the colonial nesting and feeding behaviors characteristic of feral and domestic pigeon flocks. The virus is shed predominantly in oral, ocular, and pharyngeal secretions, with the oropharyngeal mucosa representing the primary portal of entry and exit. Latently infected birds constitute the critical reservoir for viral persistence, periodically reactivating and shedding virus, often without overt clinical signs. This carrier state is the engine of endemicity, ensuring that the virus remains entrenched within populations even in the face of high seroprevalence.

The high prevalence of subclinical infection is a critical feature that distinguishes PiHV epidemiology from the more clinically overt diseases caused by other alphaherpesviruses. For instance, while BoHV-1 infection in cattle is associated with well-defined respiratory and reproductive syndromes that facilitate diagnosis [4, 20], PiHV infection in adult pigeons is frequently asymptomatic or manifests only as mild pharyngitis. A retrospective study of PiHV infection in domestic pigeons in California over a 23-year period (1991–2014) revealed a startling epidemiological reality: PiHV was often a secondary diagnosis or an incidental finding [10]. In 35 of 62 cases reviewed, PiHV was not the primary cause of morbidity, underscoring the virus's ability to circulate silently within a flock. Furthermore, the study documented that 55 of 62 cases had one to four concurrent infections, most notably pigeon circovirus (26 cases) and Trichomonas spp. (24 cases) [10]. This frequent co-infection profile suggests that PiHV may act as an opportunistic pathogen, exploiting immunosuppression induced by other agents to reactivate and amplify its transmission. This is mechanistically analogous to the role of stress and co-infections in reactivating BoHV-1 from latency in cattle, where corticosteroids and immune suppression are known triggers [4]. The World Organisation for Animal Health (WOAH) recognizes the economic significance of such polymicrobial diseases in poultry and companion birds, highlighting the need for comprehensive diagnostic approaches.

Interspecies Spillover: The Predator-Prey Nexus

The most consequential aspect of PiHV transmission dynamics is its capacity for lethal spillover into raptorial birds and, more recently, non-raptorial avian species. The primary mechanism for this interspecies transmission is trophic, the ingestion of infected pigeon meat or tissues by predators. This route is epidemiologically distinct from the respiratory droplet transmission that dominates within Columbiform populations and aligns more closely with the transmission dynamics observed in other alphaherpesviruses that cross species barriers via direct contact with infected prey or contaminated fomites.

Phylogenetic and molecular epidemiological evidence from Poland provides robust support for this transmission pathway. In a landmark study, Woźniakowski et al. (2013) detected PiHV DNA in 20.4% (18/88) of examined birds, which included rock pigeons, birds of prey (e.g., Peregrine Falcons, Falco peregrinus), and non-raptorial free-ranging birds [1]. Crucially, nucleotide sequencing of the DNA-dependent DNA polymerase gene revealed 100% identity among Polish PiHV strains, irrespective of the host species from which they were isolated [1]. This genetic monomorphism across such a diverse array of avian hosts is powerful evidence that a single viral lineage is circulating, and that spillover events are recent and frequent, rather than the result of long-term adaptation to new hosts. The study’s confirmation of PiHV infection in four non-raptorial birds for the first time further expands the known host range and raises questions about alternative transmission routes, possibly involving scavenging or environmental contamination.

The clinical outcome of spillover is often devastating. Infected raptors, including falcons and owls, frequently develop a fulminant, necrotizing hepatitis and splenitis, leading to rapid death. The observation of neurological signs in a Peregrine Falcon during the Polish study [1] suggests that the virus can invade the central nervous system in aberrant hosts, a feature reminiscent of the neuropathogenic potential of EHV-1 strains in equids, where the D752 genotype is strongly associated with equine herpesvirus myeloencephalopathy (EHM) [12, 14, 16]. However, while EHV-1 neuropathogenicity is linked to specific genetic polymorphisms in the DNA polymerase gene (ORF30) [12, 16], the neurological signs in the PiHV-infected falcon occurred without evidence of a unique neurotropic genotype, suggesting that pathology in the aberrant host may be driven by host factors, such as an uncontrolled innate immune response or a lack of species-specific viral restriction factors, rather than by a specific viral mutation.

Cellular and Molecular Mechanisms Facilitating Spillover

The capacity of PiHV to infect such a wide range of species is a testament to its molecular adaptability. From a mechanistic perspective, the virus must navigate a series of host barriers, including cell attachment, entry, and intracellular innate immune evasion. While the specific entry mechanisms of PiHV remain largely uncharacterized, comparative analysis with other alphaherpesviruses provides a framework for understanding its promiscuity.

Herpesvirus entry is a multi-step process requiring interactions between viral glycoproteins and host cell receptors. For BoHV-1, entry into bovine cells is mediated by a low-pH-dependent endocytic pathway, requiring dynamin and the acidification of endosomes [7]. Similarly, feline herpesvirus 1 (FHV-1) utilizes a pH-dependent endocytosis mechanism that involves both caveolin- and clathrin-mediated pathways, depending on the cell type [3]. Given the phylogenetic conservation of entry machinery among alphaherpesviruses, it is highly plausible that PiHV utilizes a similar endocytic route, potentially binding to ubiquitously expressed cell surface receptors such as heparan sulfate proteoglycans (HSPGs) or nectin family members. The reliance on such common receptors would inherently broaden the host range, allowing PiHV to attach to and enter cells from a wide variety of avian species.

Once inside the cell, the virus must disarm the host’s antiviral defenses. Alphaherpesviruses are masters of immune evasion, employing a battery of tegument proteins to antagonize interferon signaling. For instance, the UL41 tegument protein of BoHV-1 directly targets the STAT1 transcript for degradation, thereby blocking the JAK-STAT signaling pathway and inhibiting the expression of interferon-stimulated genes (ISGs) [5]. The BoHV-1 protein bICP0 also counteracts innate immune responses [4]. If PiHV possesses functional homologs of these immune-evasion proteins, it could effectively suppress the interferon response in a newly infected raptor, allowing for rapid viral replication before an adaptive immune response can be mounted. The severe, necrotizing pathology seen in aberrant hosts suggests that this immune suppression is not perfectly regulated, leading to uncontrolled viral replication and immunopathology rather than a balanced, persistent infection.

Another critical aspect of transmission is the virus’s ability to spread within the host. EHV-1 demonstrates a sophisticated strategy for systemic dissemination by exploiting T lymphocytes. The virus infects activated CD4+ T cells, where it restricts the expression of viral glycoproteins on the cell surface (preventing immune recognition) and hampers the release of progeny virions [6]. Instead, viral nucleocapsids accumulate in the T cell nucleus. Upon contact with endothelial cells, late viral proteins orchestrate the formation of a viral synapse, facilitating the transfer of viral progeny directly to the target cell [6]. This “Trojan horse” mechanism allows EHV-1 to traffic from the respiratory tract to the endothelium of the central nervous system or reproductive tract, causing myeloencephalopathy or abortion, respectively [6, 14]. Given that PiHV can cause neurological and hepatic lesions in raptors and non-raptorial birds [1, 10], it is plausible that it employs a similar leukocyte-associated viremia to reach target organs. The ability to hijack immune cells as vehicles for dissemination would be a powerful adaptation for a virus that transitions between species with vastly different immune systems and anatomical architectures.

The Role of Viral Genetics and Recombination in Host Range Expansion

The potential for PiHV to adapt to new hosts is intimately linked to its genetic plasticity. While the DNA polymerase gene of the Polish isolates showed 100% identity [1], this does not preclude variation in other genomic regions that could influence host tropism or virulence. Studies of other equine and bovine alphaherpesviruses have demonstrated that recombination is a major driver of genetic diversity and pathogenesis. For equine herpesvirus 4 (EHV-4), widespread natural recombination has been documented among field isolates, contributing to antigenic variation and potentially host adaptation [8]. In contrast, EHV-1 appears to be more genetically stable, with recombination events detected less frequently [8]. However, when recombination does occur in EHV-1, it can involve other equine herpesviruses, such as EHV-4 and EHV-8 [12].

For PiHV, the presence of co-infections (e.g., with circovirus and Trichomonas [10]) could create conditions favorable for co-infection of cells and subsequent recombination, not only between different PiHV strains but potentially with other avian herpesviruses. The detection of PiHV in non-raptorial birds (e.g., corvids or waterfowl) may represent dead-end spillover events, but it also provides opportunities for the virus to encounter and recombine with other alphaherpesviruses resident in those hosts. Such genetic exchange could generate novel chimeric viruses with altered host ranges or increased virulence, posing a significant threat to avian biodiversity and potentially to domestic poultry. The role of recombination in shaping the evolution of PiHV remains a critical knowledge gap that demands urgent investigation, particularly given the global trade in racing pigeons and the increasing proximity of wild and domestic bird populations.

Environmental and Anthropogenic Drivers of Transmission

The transmission dynamics of PiHV are not solely governed by intrinsic virological factors; they are profoundly influenced by environmental conditions and human activity. The seasonal pattern of PiHV outbreaks in pigeons, often peaking during the breeding season, likely reflects increased stress, crowding, and shedding rates associated with reproduction. Stress-induced immunosuppression, analogous to the corticosteroid-driven reactivation of BoHV-1 in cattle [4], is a potent trigger for viral recrudescence in latently infected pigeons.

Anthropogenic factors amplify the risk of interspecies spillover. The practice of feeding feral pigeon flocks in urban environments increases bird density and creates concentrated sources of infection. The release of racing or homing pigeons for sport can disperse infected birds over vast distances, introducing the virus to naive populations. Furthermore, the use of live prey (e.g., day-old chicks or pigeons) to feed captive falcons and raptors in rehabilitation centers or falconry operations represents a direct and high-risk route for PiHV introduction into these vulnerable populations. The lack of routine screening of feeder pigeons for PiHV is a critical biosecurity gap.

Finally, the role of fomites in environmental transmission should not be underestimated. Herpesviruses can persist on surfaces for hours to days, depending on temperature and humidity. Contaminated food and water sources, perches, and transport crates can serve as indirect vectors for both intraspecies and interspecies transmission. The World Health Organization (WHO) and WOAH guidelines for biosecurity in avian populations emphasize the importance of disinfection protocols and quarantine measures to prevent the introduction of novel pathogens like PiHV into naive ecosystems and commercial operations. The emerging threat of PiHV spillover into non-raptorial birds, as documented in Poland [1], signals that the ecological risk horizon is expanding, necessitating a One Health approach that integrates wildlife health, domestic animal management, and environmental monitoring.

Current and Emerging Therapeutic Strategies for CoHV-1 Infection

The management of Columbid herpesvirus-1 (CoHV-1) infection in domestic pigeons, raptors, and a growing spectrum of incidental hosts remains a formidable clinical challenge, one that is currently characterized by a striking paucity of rigorously evaluated antiviral interventions. Unlike the more extensively studied alphaherpesviruses of veterinary significance, such as equine herpesvirus-1 (EHV-1), bovine herpesvirus-1 (BoHV-1), and feline herpesvirus-1 (FHV-1), CoHV-1 therapeutic protocols are largely extrapolated from heterologous models, anecdotal field reports, and the broader principles of herpesvirus chemotherapy. This section critically examines the current state of CoHV-1 therapeutics, dissects the virological and immunological obstacles that hinder treatment efficacy, and explores emerging strategies informed by mechanistic studies of related herpesviruses. The discussion is anchored in the recognition that CoHV-1 infection is rarely a monopathogenic event; the high frequency of concurrent infections, particularly with pigeon circovirus, Trichomonas gallinae, Aspergillus spp., and Escherichia coli [10], fundamentally complicates therapeutic outcomes and demands a holistic, multi-agent approach.

The Core Challenge: Latency, Immune Evasion, and the Limitations of Direct Antivirals

The therapeutic landscape for CoHV-1 is profoundly shaped by the virus’s capacity to establish lifelong latency in sensory ganglia and its arsenal of immune evasion strategies, which are shared, in principle, with other alphaherpesviruses. The inability of any currently approved veterinary compound to eliminate latent virus means that therapeutic goals are necessarily limited to reducing the severity of acute clinical signs, curtailing viral shedding, and mitigating the risk of reactivation. Drawing from the extensive literature on BoHV-1, it is clear that stress-induced reactivation is a critical driver of recrudescent disease. In cattle, the synthetic corticosteroid dexamethasone consistently reactivates BoHV-1 from latency by directly stimulating viral gene expression and simultaneously impairing antiviral immune responses [4]. For the avian practitioner, this implies that any management or therapeutic intervention that fails to address concurrent stressors, overcrowding, poor nutrition, subclinical parasitism, or transport, is likely to be suboptimal. The epidemiological reality of CoHV-1 in domestic pigeons, where the virus is frequently detected as a secondary or incidental finding alongside other pathogens [10], underscores that effective therapy must target the entire polymicrobial complex, not the herpesvirus in isolation.

From a molecular perspective, alphaherpesviruses have evolved sophisticated mechanisms to dismantle the host interferon (IFN) response. BoHV-1, for example, deploys the tegument protein UL41 to directly target and cleave STAT1 mRNA, thereby blocking the JAK-STAT signaling pathway and suppressing the generation of interferon-stimulated genes (ISGs) [5]. Furthermore, productive BoHV-1 infection stimulates inflammasome formation, including the upregulation of IFI16 and NLRP3, leading to caspase-1 activation and the release of pro-inflammatory cytokines, which paradoxically may contribute to the clinical pathology observed in infected tissues [24]. While these specific molecular countermeasures have not been formally demonstrated in CoHV-1, the phylogenetic relatedness of the alphaherpesvirinae subfamily [1] strongly suggests analogous mechanisms are at play. This immune subversion presents a significant hurdle for antiviral therapy, as the virus actively sabotages the very innate immune pathways that endogenous or exogenously administered type I interferons would otherwise harness.

Current Antiviral Chemotherapy: Acyclovir, Valacyclovir, and the Translational Gap

The cornerstone of antiviral therapy for CoHV-1 infection in pigeons, particularly in outbreaks with high morbidity or in valuable aviary collections, has historically been the administration of nucleoside analogues, most commonly acyclovir (ACV) and its prodrug valacyclovir (VACV). This practice is a direct translational application from human herpes simplex virus (HSV-1) therapy and from the more robust veterinary literature on FHV-1, where topical and systemic acyclovir has demonstrated efficacy in reducing ocular and respiratory signs [18]. The theoretical basis is sound: acyclovir is phosphorylated by the viral thymidine kinase (TK) to its active triphosphate form, which then competitively inhibits the viral DNA polymerase, leading to chain termination.

However, the evidence base for acyclovir efficacy in CoHV-1 is alarmingly thin. No randomized, placebo-controlled clinical trials have been published evaluating the pharmacokinetics, safety, or efficacy of acyclovir in Columba livia. The dosages used in practice are typically extrapolated from feline protocols (e.g., 5–10 mg/kg twice daily for acyclovir, or 50 mg/kg three times daily for valacyclovir in cats [18]), often with uncertain absorption and bioavailability in the avian species. Furthermore, the in vitro sensitivity of CoHV-1 isolates to acyclovir has not been systematically assessed. Given the known variability in thymidine kinase substrate specificity among different herpesviruses, it is not safe to assume that CoHV-1 is universally susceptible. The emergence of acyclovir-resistant strains in human herpesvirus infections, often due to TK mutations, is a well-documented phenomenon; the potential for similar resistance to develop in intensively managed pigeon flocks under prolonged sub-therapeutic dosing is a real, albeit unquantified, risk.

Another critical limitation lies in the timing of antiviral initiation. In EHV-1 infection, antiviral treatment is most effective when begun very early in the course of disease, ideally before the onset of neurological signs [14]. By the time a pigeon presents with characteristic diphtheritic membranes, hepatic necrosis, or neurological deficits, the latter having been documented in a peregrine falcon with CoHV-1 [1], viral replication may have already peaked, and the pathological damage may be largely immune-mediated. The administration of acyclovir at this stage may have minimal impact on clinical outcome. This reality reinforces the need for rapid, sensitive diagnostic tools. The recent development of a TaqMan probe-based quantitative PCR for pigeon adenovirus type I, which showed no cross-reactivity with pigeon herpesvirus [15], highlights the potential for similarly specific and rapid molecular assays for CoHV-1, which could allow for earlier therapeutic intervention.

Emerging Strategies: Insights from the Herpesvirus Entry and Replication Cycles

A deeper understanding of the molecular virology of related alphaherpesviruses is now illuminating potential new therapeutic targets for CoHV-1. One such target is the specific pathway by which the virus enters the host cell. BoHV-1 has been shown to enter Madin Darby bovine kidney (MDBK) cells via a low-pH-mediated endocytosis pathway, a process that is critically dependent on endosomal acidification and proteasome activity. Treatment of cells with lysosomotropic agents such as ammonium chloride or monensin, which block endosome acidification, inhibits BoHV-1 entry in a dose-dependent manner, as does the proteasome inhibitor MG132 [7]. Similarly, FHV-1 enters feline cells via pH- and dynamin-dependent endocytosis, with specific involvement of caveolin-mediated and clathrin-mediated pathways [3]. These findings suggest that small molecule inhibitors of endosomal acidification, endocytic trafficking, or proteasomal function could theoretically be repurposed as broad-spectrum anti-herpesvirus agents, potentially including activity against CoHV-1. While such compounds are unlikely to be clinically viable in a live bird due to systemic toxicity, they provide a proof-of-concept for targeting the entry phase, and they open the door to screening libraries of FDA-approved drugs for inhibitors of the specific endocytic machinery hijacked by CoHV-1.

Another emerging area is the exploration of metal-based nanoparticles. Silver nanoparticles (Ag-NPs) have demonstrated potent in vitro antiviral activity against BoHV-1, protecting MDBK cell cultures from infection when applied at non-cytotoxic concentrations (24 μg/mL) prior to viral inoculation [23]. The mechanism is thought to involve direct interaction of Ag-NPs with the viral envelope glycoproteins, preventing attachment and entry. Although this work is strictly in vitro, it suggests a novel class of virucidal agents that could, in principle, be formulated for topical application to mucosal surfaces (e.g., the oropharynx and crop) in pigeons. The use of nanoparticles in avian medicine, however, faces substantial hurdles, including potential environmental toxicity, the risk of aspiration pneumonia from aerosolized formulations, and a lack of safety data in birds.

Immunomodulatory Approaches and the Lessons from Equine Herpesvirus

Given the limitations of direct antivirals, there is a growing rationale for exploring immunomodulatory strategies, particularly those aimed at augmenting cell-mediated immunity. The response of the horse to EHV-1 provides a compelling paradigm. EHV-1 is a master at exploiting T lymphocytes to disseminate through the body via cell-associated viremia, yet it restricts the expression of viral glycoproteins on the infected T-cell surface to avoid immune recognition. Upon contact with target endothelial cells, a late viral protein orchestrates the formation of a virological synapse, allowing direct transfer of viral progeny [6]. Critically, EHV-1-specific gamma interferon (IFN-γ)-producing CD4+ T cells, but not CD8+ T cells, have been identified as a correlate of protection, with naturally exposed horses showing significantly higher numbers of these cells compared to those vaccinated only [22]. This suggests that any successful therapeutic or prophylactic strategy against CoHV-1 must preferentially stimulate a robust, Th1-biased cellular immune response.

The currently available commercially modified-live virus (MLV) vaccines for pigeons, while widely used, are not reliably protective against severe disease or viral shedding, a situation mirroring the shortcomings of EHV-1 vaccines [2]. The ACVIM consensus statement on EHV-1 concluded that evidence for successful vaccination or effective pharmaceutical treatment was limited [2]. For CoHV-1, no systematic efficacy trials of commercially available vaccines exist in the peer-reviewed literature. The high genetic similarity of CoHV-1 strains across Poland [1] suggests that a well-designed vaccine could theoretically provide broad coverage, but the biological complexity of the virus-host interaction may yet confound these efforts.

A promising avenue involves the use of recombinant interferon therapy. In the treatment of FHV-1 in cats, recombinant feline interferon omega (rFeIFN-ω) has shown some benefit when administered topically for ocular disease [18], though systemic use remains less well-characterized. Given that CoHV-1, like BoHV-1, likely employs mechanisms to inhibit endogenous interferon signaling [4, 5], the administration of high-dose, exogenous type I interferon could theoretically overwhelm this blockade. However, the short half-life and potential for adverse effects (e.g., fever, malaise) in a compromised pigeon must be carefully weighed.

The Critical Role of Management and Biosecurity

It is imperative to recognize that no therapeutic strategy will be successful without rigorous biosecurity and management reforms. The EHV-1 outbreak epidemiology provides a stark warning. A detailed analysis of a major EHV-1 outbreak at a show-jumping competition in Valencia demonstrated that environmental factors, specifically, the location of horses in the middle of a poorly ventilated tent, were significant risk factors for developing equine herpesvirus myeloencephalopathy (EHM) [13]. Male sex and age over 9 years were also identified as independent risk factors for EHV-1 infection and EHM, respectively [13]. For the pigeon loft, these findings translate into an urgent need for optimization of ventilation, reduction of stocking density, and rigorous quarantine of new or returning birds. The high seroprevalence and widespread nature of alphaherpesviruses in intensively managed livestock, such as the 71.3% herd-level seroprevalence of BoHV-1 in Brazilian cattle [21] and 80% herd-level exposure in Irish dairy herds [20], should serve as a cautionary tale for pigeon fanciers. Without stringent management, chemotherapeutic interventions become merely a costly and ultimately futile exercise in damage control.

Furthermore, the complex polymicrobial nature of CoHV-1 disease demands targeted ancillary therapies. The most common concurrent infections identified in the California retrospective study were circovirus, trichomonosis, aspergillosis, and colibacillosis [10]. Antiviral therapy must therefore be paired with appropriate antiprotozoal (e.g., metronidazole or carnidazole for trichomonosis), antifungal (e.g., itraconazole or voriconazole for aspergillosis), and antibacterial (based on culture and sensitivity) agents. The failure to address these coinfections will inevitably lead to treatment failure, as the immunosuppressive effects of circovirus [10] and the mucosal damage caused by trichomonads create a permissive environment for unbridled herpesvirus replication.

Finally, the development of reliable, quantitative molecular diagnostics is a prerequisite for advancing therapeutic strategies. The existing TaqMan real-time PCR assays for other avian pathogens, such as pigeon adenovirus type I [15], demonstrate the feasibility of this approach. A quantitative PCR for CoHV-1 DNA polymerase gene, similar to the molecular characterization tools used in phylogenetic studies [1], would allow clinicians to monitor viral load dynamics in response to therapy, identify subclinical shedders requiring isolation, and distinguish acute infection from latent viral carriage in clinical samples.

Prevention, Biosecurity, and Vaccination Strategies for CoHV-1 Control

The control of Columbid herpesvirus 1 (CoHV-1) within domestic and feral pigeon populations, as well as the protection of susceptible non-columbid species, represents a formidable challenge that demands a multi-faceted, evidence-based strategy. Unlike many viral pathogens for which robust, commercially available vaccines and standardized eradication protocols exist, the management of CoHV-1 is complicated by the virus’s ability to establish lifelong latency in its natural host, its capacity for asymptomatic shedding, and its demonstrated potential for cross-species transmission to raptors and other avian species [1]. The epidemiological reality, as underscored by phylogenetic analyses demonstrating high genetic similarity among strains isolated from pigeons, falcons, and non-raptorial birds, indicates that biosecurity failures in one species can have cascading consequences for sympatric wildlife [1]. Therefore, an effective control program must integrate rigorous biosecurity protocols, strategic vaccination (where applicable), and a deep understanding of the viral and host factors that facilitate transmission and disease.

Foundational Biosecurity Principles for CoHV-1 Management

Biosecurity remains the cornerstone of CoHV-1 prevention, given that even the most effective vaccines against alphaherpesviruses rarely provide sterilizing immunity or prevent the establishment of latency [2, 3, 7]. The overarching goal of a biosecurity plan is to break the chain of transmission, which for CoHV-1 occurs primarily via the fecal-oral and respiratory routes, often through contaminated fomites, feed, and water sources. The initial step in any biosecurity program is the establishment of a rigorous quarantine protocol for all incoming birds. The minimum quarantine period should be no less than 30 days, a duration based on the incubation period of the virus and the time required for seroconversion. During this period, new arrivals should be housed in a physically separate airspace, with dedicated equipment (feeders, waterers, and cleaning tools) that is not shared with the main flock. Quarantine should be accompanied by diagnostic testing. While conventional PCR has been the mainstay, the development of highly sensitive TaqMan probe-based quantitative PCR (qPCR) assays, as demonstrated for pigeon adenovirus but with clear applicability to CoHV-1, offers a rapid and sensitive tool for detecting low-level viral shedding that might be missed by less sensitive methods [15]. Such qPCR assays can detect viral DNA at concentrations as low as 14.6 copies/µL, providing a crucial early warning system [15]. It is essential to test not only for CoHV-1 but also for common concurrent pathogens, as retrospective studies have shown that CoHV-1 infection in domestic pigeons is frequently accompanied by pigeon circovirus, trichomonosis, aspergillosis, and colibacillosis [10]. The presence of these coinfections can exacerbate disease severity and complicate diagnosis, making a comprehensive health screening a non-negotiable component of quarantine.

Beyond quarantine, the fundamental principles of "all-in/all-out" management and strict sanitation are critical. Facilities must be designed to minimize fecal contamination of feed and water. The use of raised wire floors, automated watering systems that prevent backflow contamination, and regular, thorough disinfection of surfaces with agents effective against enveloped viruses (e.g., accelerated hydrogen peroxide, dilute bleach solutions, or quaternary ammonium compounds) is non-negotiable. The role of environmental stress as a trigger for viral reactivation cannot be overstated. Studies on bovine herpesvirus 1 (BoHV-1) have elegantly demonstrated that stress, mimicked by synthetic corticosteroids, directly stimulates viral gene expression and replication while simultaneously impairing antiviral immune responses [4]. This mechanism is highly conserved across alphaherpesviruses. Consequently, management practices that minimize crowding, ensure optimal ventilation, provide a nutritionally balanced diet, and reduce transport and handling stress are not merely welfare considerations but are central to preventing the recrudescence of latent CoHV-1 and subsequent shedding into the environment. Furthermore, the epidemiological lessons learned from equine herpesvirus-1 (EHV-1) outbreaks are directly translatable to pigeon management. Data from a major EHV-1 outbreak at a show-jumping competition revealed that stable design and ventilation were crucial risk factors; horses housed in the middle of a poorly ventilated tent were significantly more likely to develop severe disease [13]. For pigeon lofts, this translates to ensuring adequate air exchange to dilute viral particles and prevent the build-up of aerosolized virus, a factor that is particularly critical in indoor or enclosed racing lofts.

Vaccination: Current State, Limitations, and Future Horizons

The development and deployment of effective vaccines against CoHV-1 faces the same inherent obstacles that plague vaccine development for other alphaherpesviruses, including EHV-1, feline herpesvirus 1 (FHV-1), and BoHV-1. A fundamental challenge is that current commercial vaccines, even those that reduce the severity of clinical disease, do not prevent infection, do not prevent the establishment of latency, and do not reliably prevent virus shedding upon reactivation [2, 3, 7]. This was explicitly noted in the context of FHV-1, where the available vaccine reduces disease severity but does not prevent infection or limit virus shedding [3]. Similarly, for EHV-1, a recent consensus statement from the American College of Veterinary Internal Medicine concluded that evidence for successful vaccination against infection or effective treatment was limited [2]. This reality places a heavy burden on biosecurity to compensate for vaccine shortcomings.

Currently, there is a critical deficit in the availability of robust, commercially licensed vaccines specifically tailored for CoHV-1 in pigeons. Where inactivated or modified-live vaccines against related alphaherpesviruses are used in an off-label or extralabel manner, their efficacy is questionable and must be interpreted with caution. The genetic diversity of alphaherpesviruses, even among closely related strains, poses a significant hurdle. Studies on EHV-1 have revealed that up to 13 viral clades have been circulating, and recombination between clades has been documented, which can lead to the emergence of novel strains with unpredictable antigenic properties [12]. While phylogenetic analysis of CoHV-1 strains from Poland showed high similarity (100% among Polish strains), a comparison with a German strain showed a slight dissimilarity (99.1%), suggesting that geographic variation exists and that a vaccine developed from one regional isolate may not provide optimal protection in another area [1].

The ideal vaccine for CoHV-1 must target the key features of pathogenesis. This includes stimulating a robust neutralizing antibody response against the viral glycoproteins involved in attachment and entry, as well as a strong cell-mediated immune response, particularly by CD4+ and CD8+ T lymphocytes, to control the cell-associated viremia and limit the spread of virus to target organs [6]. Research into immunological correlates of protection for EHV-1 provides a useful framework. Studies have demonstrated that natural exposure to EHV-1 induces a broader IgG isotype response and higher numbers of EHV-1-specific IFN-γ-producing CD4+ T cells compared to vaccination with a modified-live virus (MLV) vaccine [22]. This suggests that current MLV vaccines may be under-stimulating the immune response, leaving animals vulnerable. For CoHV-1, a future vaccine should ideally be designed to produce a "natural infection-like" immune profile, one that includes durable, high-avidity IgG responses and a robust, multi-functional T-cell compartment. However, vaccination carries its own risks. The use of modified-live vaccines raises concerns about reversion to virulence, a documented risk for other herpesviruses [2]. Perhaps more concerning for CoHV-1 is the potential for vaccine virus to recombine with circulating field strains, potentially generating more pathogenic or host-range-extended variants. Evidence of natural recombination has been found in other alphaherpesviruses, including equine herpesvirus 4 (EHV-4), and while it appears less common in EHV-1, the risk cannot be dismissed [8]. Any live vaccine candidate for CoHV-1 would require extensive safety testing in both pigeons and target non-columbid species, such as raptors, to ensure it does not cause disease in these highly susceptible hosts [1].

Antiviral Strategies and Immune Modulation as Adjunctive Measures

In the absence of a fully protective vaccine, direct-acting antiviral agents represent a critical adjunctive strategy, particularly for controlling outbreaks in valuable breeding stock or for treating individual, clinically affected birds. While no drugs are licensed for CoHV-1, the translational use of nucleoside analogues developed for human and feline herpesviruses is a logical avenue for investigation [18]. Acyclovir and its prodrug valacyclovir, which are effective against human herpes simplex virus, have shown variable efficacy against FHV-1 in vitro and in vivo, with the key challenge being to achieve therapeutic drug concentrations in the target tissues without causing toxicity, particularly renal or hepatic damage [18]. The use of such drugs in pigeons would require rigorous pharmacokinetic and safety studies. More novel approaches are also emerging from research on other herpesviruses. For instance, silver nanoparticles (Ag-NPs) have demonstrated a potent in vitro inhibitory effect against BoHV-1, protecting cell cultures from infection when administered prior to viral challenge [23]. While the mechanism is not fully understood, it is hypothesized to involve direct interaction with the viral envelope glycoproteins or interference with viral entry. Should such nanotechnology-based approaches prove safe and efficacious in vivo in avian species, they could offer a new tool for topical or systemic prophylaxis in high-risk scenarios.

Understanding the intricate mechanisms by which alphaherpesviruses evade the host immune response also opens doors for host-directed therapies. BoHV-1, for example, encodes the tegument protein UL41, which directly cleaves STAT1 mRNA, thereby blocking interferon signaling and the induction of antiviral interferon-stimulated genes (ISGs) [5]. Similarly, BoHV-1 counteracts immune responses by infecting and inducing apoptosis in CD4+ T cells, leading to a transient but profound immunosuppression [4]. EHV-1 has evolved a sophisticated strategy to "bridge" T lymphocytes, infecting them and using them as cellular vehicles to reach target organs while restricting the expression of viral glycoproteins on the cell surface to avoid immune recognition [6]. If CoHV-1 employs analogous immune evasion tactics, therapies that specifically inhibit these viral proteins (e.g., small molecule inhibitors of UL41-like endoribonucleases) could restore the host's natural antiviral capacity. Furthermore, since reactivation from latency is triggered by stress-induced corticosteroid signaling [4], management strategies that reduce stress remain the most effective, non-pharmacological intervention to prevent active disease in latently infected flocks.

Integrated Control and the Role of Surveillance

A truly effective control strategy for CoHV-1 must be integrated and adaptable. For the racing and show pigeon industry, this means implementing a hierarchical system of biosecurity. High-health-status stud lofts, which are free of CoHV-1, should operate under a strict closed-flock policy. For lofts that do introduce new stock, the quarantine protocol outlined above must be paired with qPCR-based surveillance on pooled fecal or oropharyngeal swab samples at regular intervals. The use of molecular diagnostics is critical, as infection can be subclinical, and relying on clinical observation alone will fail to detect shedding birds [10]. Serological monitoring using ELISA to detect antibodies against CoHV-1 can also help to map the infection status of a loft and identify birds that have been exposed, but it cannot differentiate between vaccinated and naturally infected animals nor identify active shedders [22].

From a One Health and wildlife conservation perspective, the management of CoHV-1 has profound implications. The virus’s ability to cause fatal neurological disease in peregrine falcons and other raptors, as well as its recent discovery in non-raptorial free-ranging birds, points to a significant threat to biodiversity [1]. Facilities that house falconry birds or rehabilitation centers must treat pigeons and pigeon products (e.g., meat used for feeding) as potential fomites. Any pigeon carcass fed to a raptor should be sourced from a CoHV-1-free, closed loft or be thoroughly cooked to inactivate the virus. The establishment of national or regional surveillance programs, perhaps modeled on the mollusc health surveillance networks like the Repamo in France that successfully tracked Ostreid herpesvirus 1 (OsHV-1) outbreaks, would be invaluable for monitoring the prevalence and spread of CoHV-1 [25]. Such programs could be coordinated by organizations like the World Organisation for Animal Health (WOAH), which provides standards for the surveillance and control of notifiable diseases in terrestrial animals, and could provide the epidemiological data needed to assess the true impact of this virus and guide future control policies. Ultimately, the prevention of CoHV-1 rests on a tripod of robust biosecurity, the eventual development of a safe and effective genetically engineered vaccine that addresses the virus’s latent and lytic phases, and a continued investment in understanding the intricate dance between the virus and its avian hosts.

References

[1] Woźniakowski G, Samorek-Salamonowicz E, Szymański P, Wencel P, Houszka M. Phylogenetic analysis of Columbid herpesvirus-1 in rock pigeons, birds of prey and non-raptorial birds in Poland. BMC Veterinary Research. 2013. DOI: https://doi.org/10.1186/1746-6148-9-52

[2] Lunn DP, Burgess B, Dorman DC, Goehring L, Gross P, Osterrieder K, et al.. Updated ACVIM consensus statement on equine herpesvirus‐1. Journal of Veterinary Internal Medicine. 2024. DOI: https://doi.org/10.1111/jvim.17047

[3] Synowiec A, Dąbrowska A, Pachota M, Baouche M, Owczarek K, Niżański W, et al.. Feline herpesvirus 1 (FHV-1) enters the cell by receptor-mediated endocytosis. Journal of Virology. 2023. DOI: https://doi.org/10.1128/jvi.00681-23

[4] Jones C. Bovine Herpesvirus 1 Counteracts Immune Responses and Immune-Surveillance to Enhance Pathogenesis and Virus Transmission. Frontiers in Immunology. 2019. DOI: https://doi.org/10.3389/fimmu.2019.01008

[5] Ma W, Wang H, He H. Bovine herpesvirus 1 tegument protein UL41 suppresses antiviral innate immune response via directly targeting STAT1.. Veterinary Microbiology. 2019. DOI: https://doi.org/10.1016/j.vetmic.2019.108494

[6] Poelaert KC, Cleemput JV, Laval K, Favoreel H, Couck L, Broeck WVd, et al.. Equine Herpesvirus 1 Bridles T Lymphocytes To Reach Its Target Organs. Journal of Virology. 2019. DOI: https://doi.org/10.1128/JVI.02098-18

[7] Pastenkos G, Lee BH, Pritchard S, Nicola A. Bovine Herpesvirus 1 Entry by a Low-pH Endosomal Pathway. Journal of Virology. 2018. DOI: https://doi.org/10.1128/JVI.00839-18

[8] Vaz P, Horsington J, Hartley C, Browning GF, Ficorilli N, Studdert M, et al.. Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1.. Journal of General Virology. 2016. DOI: https://doi.org/10.1099/jgv.0.000378

[9] Larsen RW, Kiupel M, Balzer H, Agerholm J. Prevalence of canid herpesvirus-1 infection in stillborn and dead neonatal puppies in Denmark. Acta Veterinaria Scandinavica. 2015. DOI: https://doi.org/10.1186/s13028-014-0092-9

[10] Gornatti-Churria CD, Loukopoulos P, Stoute S, Shivaprasad H, Uzal F. A retrospective study of pigeon herpesviral infection in domestic pigeons in California (1991–2014) and literature review. Journal of Veterinary Diagnostic Investigation. 2023. DOI: https://doi.org/10.1177/10406387231161053

[11] Longa CS, Bruno SF, Pires AR, Romijn PC, Kimura LS, Costa CH. Human Herpesvirus 1 in Wild Marmosets, Brazil, 2008. Emerging Infectious Diseases. 2011. DOI: https://doi.org/10.3201/eid1707.100333

[12] Bryant N, Wilkie G, Russell C, Compston L, Grafham D, Clissold L, et al.. Genetic diversity of equine herpesvirus 1 isolated from neurological, abortigenic and respiratory disease outbreaks. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12809

[13] Couroucé A, Normand C, Tessier C, Pomares R, Thevenot J, Marcillaud-Pitel C, et al.. Equine herpesvirus-1 outbreak during a show-jumping competition: a clinical and epidemiological study.. Journal of Equine Veterinary Science. 2023. DOI: https://doi.org/10.1016/j.jevs.2023.104869

[14] Pusterla N, Hussey G. Equine herpesvirus 1 myeloencephalopathy.. The Veterinary clinics of North America. Equine practice. 2014. DOI: https://doi.org/10.1016/j.cveq.2014.08.006

[15] An L, Liu Q, Lan Q, Luo X, Zhao Y. Establishment of a TaqMan probe real-time quantitative PCR assay for detection of pigeon adenovirus type Ⅰ and analysis of its genetic evolution. ACTA AGRICULTURAE UNIVERSITATIS JIANGXIENSIS. 2025. DOI: https://doi.org/10.3724/aauj.2025016

[16] Negussie H, Demissie DG, Tessema TS, Nauwynck H. Equine Herpesvirus‐1 Myeloencephalopathy, an Emerging Threat of Working Equids in Ethiopia. Transboundary and Emerging Diseases. 2017. DOI: https://doi.org/10.1111/tbed.12377

[17] Kantzow MCd, Hick P, Becker J, Whittington R. Effect of water temperature on mortality of Pacific oysters Crassostrea gigas associated with microvariant ostreid herpesvirus 1 (OsHV-1 µVar). Aquaculture Environment Interactions. 2016. DOI: https://doi.org/10.3354/AEI00186

[18] Thomasy S, Maggs D. A review of antiviral drugs and other compounds with activity against feline herpesvirus-1. Veterinary Ophthalmology. 2016. DOI: https://doi.org/10.1111/vop.12375

[19] Xia J, Bai C, Wang C, Song X, Huang J. Complete genome sequence of Ostreid herpesvirus-1 associated with mortalities of Scapharca broughtonii broodstocks. Virology Journal. 2015. DOI: https://doi.org/10.1186/s12985-015-0334-0

[20] Sayers R, Byrne N, O’Doherty E, Arkins S. Prevalence of exposure to bovine viral diarrhoea virus (BVDV) and bovine herpesvirus-1 (BoHV-1) in Irish dairy herds.. Research in Veterinary Science. 2015. DOI: https://doi.org/10.1016/j.rvsc.2015.02.011

[21] Dias JA, Alfieri A, Ferreira-Neto JS, Gonçalves V, Müller EE. Seroprevalence and risk factors of bovine herpesvirus 1 infection in cattle herds in the state of Paraná, Brazil.. Transboundary and Emerging Diseases. 2013. DOI: https://doi.org/10.1111/j.1865-1682.2012.01316.x

[22] Goodman L, Wimer CL, Dubovi E, Gold C, Wagner B. Immunological Correlates of Vaccination and Infection for Equine Herpesvirus 1. Clinical and Vaccine Immunology. 2011. DOI: https://doi.org/10.1128/CVI.05522-11

[23] El-Mohamady R, Ghattas T, Zawrah M, El-Hafeiz YA. Inhibitory effect of silver nanoparticles on bovine herpesvirus-1. International Journal of Veterinary Science and Medicine. 2018. DOI: https://doi.org/10.1016/j.ijvsm.2018.09.002

[24] Wang J, Alexander J, Wiebe MS, Jones C. Bovine herpesvirus 1 productive infection stimulates inflammasome formation and caspase 1 activity.. Virus Research. 2014. DOI: https://doi.org/10.1016/j.virusres.2014.03.006

[25] Garcia C, Thébault A, Dégremont L, Arzul I, Miossec L, Robert M, et al.. Ostreid herpesvirus 1 detection and relationship with Crassostrea gigas spat mortality in France between 1998 and 2006. Veterinary Research. 2011. DOI: https://doi.org/10.1186/1297-9716-42-73